InnovAge Holding (InnovAge Holding) Interest Expense : $-2.9 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is InnovAge Holding Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. InnovAge Holding's interest expense for the three months ended in Mar. 2024 was $ -1.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. InnovAge Holding's Operating Income for the three months ended in Mar. 2024 was $ -5.8 Mil. InnovAge Holding's Interest Expense for the three months ended in Mar. 2024 was $ -1.0 Mil. InnovAge Holding did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

InnovAge Holding Interest Expense Historical Data

The historical data trend for InnovAge Holding's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovAge Holding Interest Expense Chart

InnovAge Holding Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

-9.59

-14.62

-16.79

-2.53

-1.52

InnovAge Holding Quarterly Data
	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial														-0.41	-0.29	-0.66	-0.94	-1.02

InnovAge Holding Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.9 Mil.

InnovAge Holding (NAS:INNV) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

InnovAge Holding's Interest Expense for the three months ended in Mar. 2024 was $-1.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-5.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $99.5 Mil.

InnovAge Holding's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

InnovAge Holding did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

InnovAge Holding (InnovAge Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovAge Holding Corp (NAS:INNV) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

8950 East Lowry Boulevard, Denver, CO, USA, 80230

Website

https://www.innovage.com

InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.

Executives

Teresa Sparks	director	40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Nicole Damato	officer: CHIEF LEGAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Benjamin C Adams	officer: CHIEF FINANCIAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patricia Fontneau	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Christine Bent	officer: CHIEF OPERATIONS OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Thomas Scully	director	320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022
Richard Feifer	officer: CHIEF MEDICAL OFFICER	C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348
James G Carlson	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patrick T Blair	officer: PRESIDENT	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Caroline Dechert	director	580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104
Pavithra Mahesh	director	601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022
Maureen Hewitt	director, officer: CEO, President and Director	8950 E. LOWRY BLVD., DENVER CO 80230
Maria Lozzano	officer: CORPORATE COO	8950 E. LOWRY BLVD., DENVER CO 80230
Robin Doerr	officer: CHIEF SALES AND MKTG. OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230
Melissa Welch	officer: CHIEF MEDICAL OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230